Article
MDR1 mRNA expression and MDR1 gene variants as predictors of response to chemotherapy in patients with acute myeloid leukaemia: a meta-analysis.
Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals - 1 Aug 2013
Doxani Chrysoula, Voulgarelis Michael, Zintzaras Elias
Abstract excerpt
Data from 30 pharmacogenomic studies that investigated MDR1 mRNA expression or gene variants (C3435T, G2677TA, C1236T) and response to therapy in acute myeloid leukaemia (AML) were synthesized. Anthracycline-based regimens were mainly used. MDR1 mRNA overexpression was associated with poor response to therapy [odds ratio (OR) = 2.49 95% confidence interval (CI) 1.38-4.50]. The gene variants were not associated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
